THREE PATIENTS GET BRAIN IMPLANTS FOR CANCER DETECTION

The biotech company implanted the devices in three patients as part of early-stage testing. The technology aims to use electrical signals to monitor brain activity and intervene before cancer cells proliferate. Coherence Neuro's approach represents a novel application of brain-computer interfaces, which have traditionally focused on restoring mobility or communication for paralyzed patients. The implants could eventually alert physicians to tumor development in real time. The trial marks an expansion into therapeutic uses beyond neural rehabilitation. If successful, the technology could offer a new method for early cancer detection and treatment in high-risk patients. Details on patient selection criteria and trial duration remain limited. The company plans to monitor outcomes over coming months to assess both safety and efficacy of the implant system.